Several HSP90 inhibitors can overcome the resistance to Fms-like tyrosine kinase 3 (FLT3) inhibitors that has been observed in acute myeloid leukemia (AML)18. This evidence concerns the gene HSP90AA1 and acute myeloid leukemia.